Announcement on Completion of the Non-trading Transfer of Shares for the Reserved Portion under the 2025 Employee Stock Ownership Plan
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(600867)"Tonghua Dongbao Pharmaceutical Co., Ltd."Announcement on Completion of the Non-trading Transfer of Shares for the Reserved Portion under the 2025 Employee Stock Ownership Plan
Filed with SSE · Stock code 600867 · · 3 pages · Chinese
Summary by 6ix AI
The filing details the stock transfer process and the number of shares involved, along with the pricing and approval history of the employee stock ownership plan. It also outlines the future arrangements for the stock ownership plan, including the unlocking schedule for the shares granted to employees.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Release
Tonghua Dongbao Pharmaceutical Co., Ltd. on 6ix
Story so far
- Announcement on Satisfaction of Unlocking Conditions for the First Lock-up Period of the Initial Grant under the 2025 Employee Stock Ownership Plan and Expiration of the Lock-up Period
- (600867)"Tonghua Dongbao Pharmaceutical Co., Ltd."Announcement on Pledge Release and Re-pledge of Shares Held by the Controlling Shareholder
- Announcement on Allocation of Reserved Portion under Employee Stock Ownership Plan for R&D and Production System
Earlier from Tonghua Dongbao Pharmaceutical
- Announcement on Satisfaction of Unlocking Conditions for the First Lock-up Period of the Initial Grant under the 2025 Employee Stock Ownership Plan and Expiration of the Lock-up Period
- (600867)"Tonghua Dongbao Pharmaceutical Co., Ltd."Announcement on Pledge Release and Re-pledge of Shares Held by the Controlling Shareholder
- Announcement on Allocation of Reserved Portion under Employee Stock Ownership Plan for R&D and Production System
- Announcement on Termination of an R&D Project and Provision for Asset Impairment
- Announcement on Results of Exercising the Preemptive Rights to Subscribe for the Convertible Corporate Bonds Issued to Unspecified Investors by Xiamen Amoytop Biotech Co., Ltd.
Later from Tonghua Dongbao Pharmaceutical
All Tonghua Dongbao Pharmaceutical news releasesFollow Tonghua Dongbao Pharmaceutical into a list and get an email when it puts out news.
Follow Tonghua Dongbao Pharmaceutical